Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease. (Q42488552)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

G Schlaug

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

H Hefter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

B Nebeling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

V Engelbrecht

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

G Stöcklin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

R J Seitz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 October 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

577-584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

Wilson's disease studied with FDG and positron emission tomography

26 October 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00920620

Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00920620

Neurological abnormalities in Wilson's disease are reversible

21 January 2018

1 reference

12 December 2020

Atypical MR presentation of Wilson disease: a possible consequence of paramagnetic effect of copper?

1 reference

12 December 2020

Neuropathological findings in penicillamine-treated patients with Wilson's disease

1 reference

12 December 2020

Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography

1 reference

12 December 2020

A computerized brain atlas: construction, anatomical content, and some applications

1 reference

12 December 2020

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1 reference

12 December 2020

Penicillamine, a new oral therapy for Wilson's disease

1 reference

12 December 2020

Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers.

1 reference

12 December 2020

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

1 reference

12 December 2020

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

12 December 2020

Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution

1 reference

12 December 2020

Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites

1 reference

12 December 2020

The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia

1 reference

12 December 2020

Diagnosis and treatment of presymptomatic Wilson's disease

1 reference

12 December 2020

Performance characteristics of an eight-ring whole body PET scanner

1 reference

12 December 2020

Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride

1 reference

12 December 2020

Advanced catecholaminergic disturbances in the brain in a case of Wilson's disease

1 reference

12 December 2020

Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study

1 reference

12 December 2020

Noninvasive determination of local cerebral metabolic rate of glucose in man.

1 reference

12 December 2020

Clinico-radiological correlation of Wilson's disease by magnetic resonance imaging, computed and positron emission tomography

1 reference

12 December 2020

Wilson's disease: normalisation of cortically evoked motor responses with treatment

1 reference

12 December 2020

Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging

1 reference

12 December 2020

Brain copper in Wilson's disease

1 reference

12 December 2020

Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.

1 reference

12 December 2020

Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals

1 reference

12 December 2020

The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography

1 reference

12 December 2020

Magnetic resonance imaging of the brain in Wilson's disease

1 reference

12 December 2020

Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study

1 reference

12 December 2020

Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose

1 reference

12 December 2020

Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease

1 reference

12 December 2020

Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy

1 reference

12 December 2020

Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse

1 reference

12 December 2020

Cranial MRI in Wilson's disease

1 reference

12 December 2020

Motor impairment in Wilson's disease, I: Slowness of voluntary limb movements

1 reference

12 December 2020

Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission

1 reference

12 December 2020

Hudson memorial lecture: Wilson's disease: genetics and biochemistry--their relevance to therapy

1 reference

12 December 2020

Dopamine D1 and D2 receptors in progressive supranuclear palsy: an autoradiographic study

1 reference

12 December 2020

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

12 December 2020

PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system

1 reference

12 December 2020

Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease

1 reference

12 December 2020

Cerebral abnormalities in Wilson's disease as evaluated by ultra-low-field magnetic resonance imaging and computerized image processing

1 reference

12 December 2020

Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00920620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836960%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference